Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial
Authors
Keywords
-
Journal
DIABETOLOGIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-05
DOI
10.1007/s00125-022-05768-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Fecal Microbiota Is Already Altered in Normoglycemic Individuals Who Go on to Have Type 2 Diabetes
- (2021) Li Wang et al. Frontiers in Cellular and Infection Microbiology
- Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
- (2021) Noel T. Mueller et al. DIABETES CARE
- Implication of the gut microbiome composition of type 2 diabetic patients from northern China
- (2020) Qian Li et al. Scientific Reports
- Gut microbiota in human metabolic health and disease
- (2020) Yong Fan et al. NATURE REVIEWS MICROBIOLOGY
- Gut microbiome-related effects of berberine and probiotics on type 2 diabetes (the PREMOTE study)
- (2020) Yifei Zhang et al. Nature Communications
- Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies
- (2020) Thao T. B. Cao et al. Frontiers in Endocrinology
- Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis
- (2019) Xiaoyu Liao et al. EBioMedicine
- Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics
- (2019) Huanzi Zhong et al. EBioMedicine
- The impact of short-chain fatty acids on GLP-1 and PYY secretion from the isolated perfused rat colon
- (2018) Charlotte Bayer Christiansen et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Comparison of Placebo Effect between Asian and Caucasian Type 2 Diabetic Patients: A Meta-Analysis
- (2018) Wei Guo et al. CHINESE MEDICAL JOURNAL
- The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice
- (2018) Marta Olivares et al. DIABETOLOGIA
- A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
- (2018) Li Zhao et al. Frontiers in Endocrinology
- Extensive impact of non-antibiotic drugs on human gut bacteria
- (2018) Lisa Maier et al. NATURE
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Species-level functional profiling of metagenomes and metatranscriptomes
- (2018) Eric A. Franzosa et al. NATURE METHODS
- Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals
- (2017) Mansour Sedighi et al. MICROBIAL PATHOGENESIS
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats
- (2017) Qian Zhang et al. PLoS One
- Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment
- (2017) Yanyun Gu et al. Nature Communications
- Optimizing methods and dodging pitfalls in microbiome research
- (2017) Dorothy Kim et al. Microbiome
- Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
- (2016) Lin Wang et al. Scientific Reports
- Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein–Coupled Bile Acid Receptors
- (2015) Cheryl A. Brighton et al. ENDOCRINOLOGY
- MetaPhlAn2 for enhanced metagenomic taxonomic profiling
- (2015) Duy Tin Truong et al. NATURE METHODS
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- Ghrelin
- (2015) T.D. Müller et al. Molecular Metabolism
- Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report
- (2013) Miao-yan Zheng et al. Cardiovascular Diabetology
- Gut metagenome in European women with normal, impaired and diabetic glucose control
- (2013) Fredrik H. Karlsson et al. NATURE
- Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial
- (2013) Wenying Yang et al. Lancet Diabetes & Endocrinology
- DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis
- (2012) Matteo Monami et al. ADVANCES IN THERAPY
- Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
- (2012) DIABETES CARE
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein-Coupled Receptor FFAR2
- (2011) G. Tolhurst et al. DIABETES
- TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
- (2009) Charles Thomas et al. Cell Metabolism
- Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine
- (2009) Petra Louis et al. FEMS MICROBIOLOGY LETTERS
- Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
- (2008) Peter et al. Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started